Immunoregulatory Networks in Chlamydia Genital Tract Infection
衣原体生殖道感染的免疫调节网络
基本信息
- 批准号:8196982
- 负责人:
- 金额:$ 13.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-12-25 至 2013-11-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdoptive TransferAdvisory CommitteesAnimal ModelArkansasBasic ScienceBiological MarkersCD4 Positive T LymphocytesCellsChlamydiaChlamydia InfectionsChlamydia trachomatisChronicDataDevelopmentDisease OutcomeDisease ProgressionDoctor of MedicineEctopic PregnancyEdemaEnvironmentEpithelialFellowshipFosteringFrequenciesFutureGenerationsGenital systemGoalsHistologicHumanHypersensitivityImmune responseImmunologyInfectionInfertilityInflammatoryInflammatory InfiltrateInflammatory ResponseInterleukin-17Interleukin-4InterventionKineticsKnockout MiceKnowledgeLaboratoriesLinkLymphocyteMediatingMedicalMentorsMentorshipMusOutcomePathologicPathologyPediatric HospitalsPelvic Inflammatory DiseasePopulationPredispositionPrevalencePrevention strategyPrincipal InvestigatorPublic HealthRegulatory T-LymphocyteResearchResearch InstituteResearch PersonnelResolutionResourcesRiskRisk FactorsRoleScienceSeriesSexually Transmitted DiseasesStructureT cell responseTestingTherapeutic InterventionTimeTissuesTraining ProgramsTranslatingUlcerUnited StatesUniversitiesVariantWorkadaptive immunityarmbasecareerclinically relevantexperiencehuman subjectimmunopathologyin vivomouse modelneutrophilpreventprofessorprogramsreproductivereproductive developmentresearch studyresponseskillstranslational study
项目摘要
DESCRIPTION (provided by applicant): Amy Scurlock, M.D., is an Assistant Professor who completed her Allergy/Immunology Fellowship in 2004. In this application, she describes a multi-faceted, 5-year research and educational training program that will expand her scientific skills by integrating the enthusiastic mentorship of her experienced sponsor, Dr. Roger Rank, and scientific advisory committee with numerous institutional resources. Sexually transmitted infections (STI) with Chlamydia trachomatis are the most common bacterial STI in both the United States and worldwide and represent a significant public health concern. At present, there are no biomarkers to predict potentially devastating reproductive complications, such as infertility and ectopic pregnancy, associated with Chlamydia infections. The research plan will evaluate the expanding diversity of effector and regulatory CD4+ T-cell responses following Chlamydia infection. The central hypothesis proposes that the CD4+ Th17 lineage is a pathologic CD4+ effector response that promotes reproductive tract pathology following Chlamydia genital tract infection. Employing a series of in vivo experiments in an established mouse model, the hypothesis will be tested by the following Specific Aims: 1) Determine the role of the Th17 response in development of reproductive tract pathology following chlamydial genital tract infection, 2) Examine the interaction between Th17 and T-regulatory cells in modulating the outcome of Chlamydia genital tract infection. Information gained from the proposed studies will advance Dr. Scurlock's immediate and long-term career objectives to expand her technical and analytical research skills, develop biomarkers for adverse disease outcomes following Chlamydia STI, and translate findings in the basic immunology laboratory into clinically relevant prevention and intervention strategies for STI. The PI will take advantage of strong mentoring, protected research time, and outstanding academic resources at the University of Arkansas for Medical Sciences and the Arkansas Children's Hospital Research Institute to reach her goal of becoming an independent investigator with an established scientific niche in genital tract mucosal immunology. RELEVANCE: Sexually transmitted Chlamydia trachomatis infections are a significant public health problem due to their high frequency and risk of reproductive complications including infertility and ectopic pregnancy. This project evaluates the newly described T-helper 17 response as an important contributor to Chlamydia-induced reproductive tract tissue damage.
简介(申请人提供):艾米·斯柯洛克,医学博士,助理教授,2004年完成过敏/免疫学研究。在这份申请中,她描述了一个多方面的、为期5年的研究和教育培训计划,该计划将通过将她的经验丰富的赞助人Roger Rank博士和科学咨询委员会的热情指导与众多机构资源相结合来扩展她的科学技能。沙眼衣原体性传播感染(STI)是美国和世界范围内最常见的细菌性STI,是一个重大的公共卫生问题。目前,还没有生物标志物可以预测与衣原体感染相关的潜在破坏性生殖并发症,如不孕症和异位妊娠。该研究计划将评估衣原体感染后效应器和调节性CD4+T细胞反应的不断扩大的多样性。中心假说认为,在衣原体生殖道感染后,CD4+Th17细胞系是一种病理性的CD4+效应器反应,促进生殖道病理。通过在已建立的小鼠模型中进行的一系列体内实验,将通过以下特定目的来检验这一假说:1)确定Th17反应在衣原体生殖道感染后生殖道病理发展中的作用;2)检查Th17与T调节细胞在调节衣原体生殖道感染结局方面的相互作用。从拟议的研究中获得的信息将推动斯柯洛克博士的近期和长期职业目标,以扩大她的技术和分析研究技能,开发针对性病衣原体感染后不良疾病后果的生物标记物,并将基础免疫学实验室的研究结果转化为与临床相关的性病预防和干预策略。PI将利用阿肯色大学医学科学大学和阿肯色州儿童医院研究所强大的指导、受保护的研究时间和出色的学术资源来实现她的目标,即成为一名在生殖道粘膜免疫学领域拥有既定科学地位的独立研究员。相关性:性传播沙眼衣原体感染是一个重大的公共卫生问题,因为它们的频率很高,而且有可能出现生殖并发症,包括不孕不育和宫外孕。该项目评估了新描述的T辅助分子17反应是衣原体引起的生殖道组织损伤的重要因素。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
AMY M. SCURLOCK其他文献
AMY M. SCURLOCK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('AMY M. SCURLOCK', 18)}}的其他基金
Immunoregulatory Networks in Chlamydia Genital Tract Infection
衣原体生殖道感染的免疫调节网络
- 批准号:
7588300 - 财政年份:2008
- 资助金额:
$ 13.23万 - 项目类别:
Immunoregulatory Networks in Chlamydia Genital Tract Infection
衣原体生殖道感染的免疫调节网络
- 批准号:
7991844 - 财政年份:2008
- 资助金额:
$ 13.23万 - 项目类别:
Immunoregulatory Networks in Chlamydia Genital Tract Infection
衣原体生殖道感染的免疫调节网络
- 批准号:
8389650 - 财政年份:2008
- 资助金额:
$ 13.23万 - 项目类别:
Immunoregulatory Networks in Chlamydia Genital Tract Infection
衣原体生殖道感染的免疫调节网络
- 批准号:
7753218 - 财政年份:2008
- 资助金额:
$ 13.23万 - 项目类别:
Project 2 - Regulation of the T-cell Memory Response in Chlamydia Genital Tract
项目 2 - 衣原体生殖道 T 细胞记忆反应的调节
- 批准号:
8460760 - 财政年份:
- 资助金额:
$ 13.23万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 13.23万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 13.23万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 13.23万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 13.23万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 13.23万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 13.23万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 13.23万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 13.23万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 13.23万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 13.23万 - 项目类别:














{{item.name}}会员




